Key Facts

Date 18 September 2025
Duration 2 Days
Location

Sendling-Westpark, Zielstattstraße 20, 81379 Munich

About this event

Calling All Innovators in Protein and RNA Therapeutics!

Are you a start-up or early-stage developer with pioneering advances in protein or RNA therapeutics? Seize the opportunity to showcase your breakthrough solutions at our upcoming Symposium, taking place on September 18th and 19th at our state-of-the-art WACKER Biotechnology Center in Munich.

Pitch your approach to an exclusive audience of industry leaders, including government authorities, renowned academic experts, executives from major pharmaceutical companies, CDMOs, successful biotech founders and venture capital partners such as HTGF.

What is in it for you?

The winner of our highly anticipated pitch session will receive:

  • Either a 10% discount for a medium throughput screening (MTS) for the best producer strain of your protein lead candidate, including small scall sampling (E. coli-based production).
  • Or a 10 % discount for a small-scale sample supply of your lead RNA candidate*
  • Expert guidance on scalability and manufacturability of Wacker
  • Strategic advice on business development and on funding opportunities from HTGF and Wacker
  • Marketing of the pitch price winner.

Are you ready to accelerate your business growth and connect with key industry stakeholders?

Apply now!

Submit a 250-word abstract outlining your innovative approach to info.biologics@wacker.com and secure your spot at the Symposium by registering here.

Don’t miss this unique chance to propel your biotech venture to the next level!

 

*Up to 3,000 € discount. The winner will be selected by a committee of industry and venture capital experts during the event based on objective evaluation criteria. The legal recourse is excluded. You will find our privacy policy under Data Protection – Wacker Chemie AG.

HTGF on site

We are there

Zum Artikel

Kay G. Balster Principal

Kay G. BalsterPrincipal

Zum Artikel

Dr. Achim Plum Managing Director

Dr. Achim PlumManaging Director

Zum Artikel

Tilmann Petersen Investment Manager

Tilmann PetersenInvestment Manager